DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Status of the Claims
Claims filed 04/14/2023 has been entered. Claims 1, 6, 16, 20, 23, 35, 40-53 are pending and under consideration.
Drawings
The drawings are objected to as failing to comply with 37 CFR 1.84(p)(5) because they include the following reference character(s) not mentioned in the description: figure 3, 203 and 204, figure 5, 320, figure 7, 409, 430, 442, figure 8, 509. Corrected drawing sheets in compliance with 37 CFR 1.121(d), or amendment to the specification to add the reference character(s) in the description in compliance with 37 CFR 1.121(b) are required in reply to the Office action to avoid abandonment of the application. Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. The objection to the drawings will not be held in abeyance.
Claim Objections
Claims 1, 6, 16, 35 and 40-53 objected to because of the following informalities:
Claim 1 line 9 “a user’s skin” which should read “the user’s skin”
Claim 6 line 2 “a user’s skin” which should read “the user’s skin”
Claim 6 line 3 recites “when the presence of skin is detected” which should read “when the presence of the user’s skin is detected”
Claim 16 lines 3-4 “a user” which should read “the user”
Claim 35 line 8” a user’s skin” which should read “the user’s skin”
Claim 40 line 10 “a user’s skin” which should read “the user’s skin”
Claim 41 line 3 recites “a skin treatment dressing” which should read “the skin treatment dressing”
Claim 42 line 9 recites “a user’s skin” which should read “the user’s skin”
Claims 43-53 line 1 recite “the apparatus” which should read “the dermatologic treatment apparatus”
Appropriate correction is required.
Claim Interpretation
The following is a quotation of 35 U.S.C. 112(f):
(f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof.
The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph:
An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof.
The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked.
As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph:
(A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function;
(B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and
(C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function.
Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function.
Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function.
Claim limitations in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action.
This application includes one or more claim limitations that do not use the word “means,” but are nonetheless being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, because the claim limitation(s) uses a generic placeholder that is coupled with functional language without reciting sufficient structure to perform the recited function and the generic placeholder is not preceded by a structural modifier.
Such claim limitation(s) is/are: “switching apparatus configured to detect the presence of a user’s skin and to switch the light emitting part on when the presence of skin is detected” in claims 2 47, 50 and 53.
For the examination purpose, The limitation is interpreted as an apparatus comprising two electrodes, mechanical switches, timed switches and wireless switches, or a combination thereof as disclosed in [0184]
Because this/these claim limitation(s) is/are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, it/they is/are being interpreted to cover the corresponding structure described in the specification as performing the claimed function, and equivalents thereof.
If applicant does not intend to have this/these limitation(s) interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, applicant may: (1) amend the claim limitation(s) to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph (e.g., by reciting sufficient structure to perform the claimed function); or (2) present a sufficient showing that the claim limitation(s) recite(s) sufficient structure to perform the claimed function so as to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph.
Claim Rejections - 35 USC § 102
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
Claims 1, 16, 20, 23,35, 40 and 42 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Anderson (US 20190240502 A1)
Regarding claim 1, Anderson teaches a dermatologic treatment apparatus (figure 3 and [0120] a device comprising LEDS 309 and dressing 307 ) comprising:
a light emitting part (figure 3 and [0120] LEDs 309), for emitting light for dermatological treatment;
wherein the apparatus further comprises a skin treatment dressing (figure 3, dressing 307);
the skin treatment dressing is a bioactive dressing ([0121] [0123] the dressing could be hydrocolloid. Hydrocolloid is a bioactive material as disclosed in the applicant’s specification [0023])
the skin treatment dressing is arranged to adhere to a user's skin, during use (figure 3 and [0120] dressing 307 adhered to skin during treatment);
the skin treatment dressing is arranged with the light emitting part such that, in use, light from the light emitting part passes to the skin treatment dressing (figure 3 [0123] the UV light from LEDs passes through self-contained portions 303 of the dressing); and,
wherein the skin treatment dressing is configured such that the light from the light emitting part passes through the skin treatment dressing to a user's skin (figure 3 [0123] the UV light from LEDs passes through self-contained portions 303 of the dressing to a user’s skin).
Regarding claim 16, Anderson teaches the dermatologic treatment apparatus according to claim 1.
Anderson further teaches wherein the skin treatment dressing comprises at least one light transmitting region (figure 3 and [0120], self-contained portions 303 are arranged to offer pathways for UV light from LEDs 309 that provides greater transmission of UV light than medicament portion 301) that is configured to provide for greater transmission of light, from the light emitting part to the skin of the user, than another region of the skin treatment dressing.
Regarding claim 20, Anderson teaches the dermatologic treatment apparatus according to claim 16.
Anderson further teaches wherein the at least one light transmitting region is a light transmitting channel (figure 3 and [0120] the self-contained portions can be channel formed in hollow tube).
Regarding claim 23, Anderson teaches the dermatologic treatment apparatus according to claim 20.
Anderson further teaches wherein the at least one light transmitting region is a region of reduced thickness of the skin treatment dressing (figure 3 and [0120] “In another embodiment, the self-contained portions only go partially through the thickness of the dressing”)
Regarding claim 35, Anderson teaches a method of dermatological treatment (abstract, figure 3 and [0120] treatment providing apparatus comprising LEDs 309 and dressing 307) comprising providing a dermatologic treatment apparatus comprising:
a light emitting part (figure 3 and [0120] LEDs 309), for emitting light for dermatological treatment;
wherein the apparatus further comprises a skin treatment dressing (figure 3, dressing 307), the skin treatment dressing is a bioactive dressing ([0121] [0123] the dressing could be hydrocolloid. Hydrocolloid is a bioactive material as disclosed in the applicant’s specification [0023]);
the skin treatment dressing is arranged to adhere to a user's skin, during use (figure 3 and [0045] [0120] dressing 307 adhered to skin during treatment); and,
wherein the skin treatment dressing is configured such that the light from the light emitting part passes through the skin treatment dressing to a user's skin ([0120] and figure 3, dressing 307 comprises non-medicament portion 303 which allows UV light to travel through the dressing to a user’s skin);
wherein the method comprises:
applying the skin treatment dressing to a skin surface to be treated and transmitting light from the light emitting part through the skin treatment dressing to the skin surface (figure 3, [0045] and [0120] applying dressing to skin surface).
Regarding claim 40, Anderson teaches a method of manufacture of a dermatologic treatment apparatus ([0088], [0137]), comprising:
providing a light emitting part (figure 3 and [0120] LEDs 309), for emitting light for dermatological treatment;
providing a skin treatment dressing (figure 3, dressing 307),
wherein the skin treatment dressing is a bioactive dressing ([0121] [0123] the dressing could be hydrocolloid, Hydrocolloid is a bioactive material as disclosed in the applicant’s specification [0023]); and
the skin treatment dressing is arranged to adhere to a user's skin (figure 3 , [0045] and [0120] applying dressing to skin surface), during use;
arranging the skin treatment dressing with the light emitting part such that, in use, light from the light emitting part passes to the skin treatment dressing (figure 3, [0045] and [0120] arranging UV light source, for example LEDs 309, with the dressing thereby the light from the LED passes through the dressing); and,
configuring the skin treatment dressing such that the light from the light emitting part passes through the skin treatment dressing to a user's skin ([0120] and figure 3, at least the dressing 307 comprises non-medicament portion 303 which allows UV light to travel through the dressing).
Regarding claim 42, Anderson teaches a kit of parts comprising:
a light emitting part (figure 3 and [0120] LEDs 309), for emitting light for dermatological treatment; and
a skin treatment dressing (figure 3, dressing 307), wherein the skin treatment dressing is a bioactive dressing ([0121] [0123] The dressing could be hydrocolloid, Hydrocolloid is a bioactive material as disclosed in the applicant’s specification [0023]);
the skin treatment dressing being arranged to adhere to a user's skin (figure 3 and [0045] and [0120] adhering the dressing to the skin during use), during use;
the skin treatment dressing is for being arranged with the light emitting part such that, in use, light from the light emitting part passes to the skin treatment dressing (figure 3 [0045] and [0120] arranging UV light source, for example LEDs 309, with the dressing thereby the light from the LED passes through the dressing); and,
wherein the skin treatment dressing is for being configured such that the light from the light emitting part passes through the skin treatment dressing to a user's skin ([0120] and figure 3, the dressing 307 comprises non-medicament portion 303 which allows UV light to travel through the dressing).
Claim Rejections - 35 USC § 103
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
Claims 6, 47, 50 and 53 are rejected under 35 U.S.C. 103 as being unpatentable over Anderson (US 20190240502 A1) in view of Asah (US 20150045843 A1)
Regarding claim 6, Anderson teaches the dermatologic treatment apparatus according to claim 1.
Anderson does not teach comprising a switching apparatus configured to detect the presence of a user’s skin and to switch the light emitting part on when the presence of skin is detected.
In the same field of endeavor, namely a hand-held device for combined light and electrotherapy of a skin surface, Asah teaches a hand-held device comprising a switching apparatus configured to detect the presence of a user’s skin and to switch the light emitting part on when the presence of skin is detected ([0125]-[0126] two mechanical switches 38, 40 for detection of contact between hand-held housing 12 and the skin surface, Therapy is started upon detecting proper contact).
Therefore, It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Anderson, to incorporate the teachings of Asah and provides the switching apparatus as claimed for the purpose of simultaneously activate the treatment as taught by Asah ([0067]). The modification ensures the light-emitting part is only active when correctly positioned against the skin, which prevents ineffective treatment or accidental exposure, while providing convenient and automated user experience.
Regarding claim 47, Anderson teaches the method according to claim 35.
Anderson does not teach comprising a switching apparatus configured to detect the presence of a user’s skin and to switch the light emitting part on when the presence of skin is detected.
In the same field of endeavor, namely a hand-held device for combined light and electrotherapy of a skin surface, Asah teaches a hand-held device comprising a switching apparatus configured to detect the presence of a user’s skin and to switch the light emitting part on when the presence of skin is detected ([0125]-[0126] two mechanical switches 38, 40 for detection of contact between hand-held housing 12 and the skin surface, Therapy is started upon detection proper contact).
Therefore, It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Anderson, to incorporate the teachings of Asah and provides the switching apparatus as claimed for the purpose of simultaneously activate the treatment as taught by Asah ([0067]). The modification ensures the light-emitting part is only active when correctly positioned against the skin, which prevents ineffective treatment or accidental exposure, while providing convenient and automated user experience.
Regarding claim 50, Anderson teaches the method according to claim 40.
Anderson does not teach comprising a switching apparatus configured to detect the presence of a user’s skin and to switch the light emitting part on when the presence of skin is detected.
In the same field of endeavor, namely a hand-held device for combined light and electrotherapy of a skin surface, Asah teaches a hand-held device comprising a switching apparatus configured to detect the presence of a user’s skin and to switch the light emitting part on when the presence of skin is detected ([0125]-[0126] two mechanical switches 38, 40 for detection of contact between hand-held housing 12 and the skin surface, Therapy is started upon detection proper contact).
Therefore, It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Anderson, to incorporate the teachings of Asah and provides the switching apparatus as claimed for the purpose of simultaneously activate the treatment as taught by Asah ([0067]). The modification ensures the light-emitting part is only active when correctly positioned against the skin, which prevents ineffective treatment or accidental exposure, while providing convenient and automated user experience.
Regarding claim 53, Anderson teaches the kit of parts according to claim 42.
Anderson does not teach comprising a switching apparatus configured to detect the presence of a user’s skin and to switch the light emitting part on when the presence of skin is detected.
In the same field of endeavor, namely a hand-held device for combined light and electrotherapy of a skin surface, Asah teaches a hand-held device comprising a switching apparatus configured to detect the presence of a user’s skin and to switch the light emitting part on when the presence of skin is detected ([0125]-[0126] two mechanical switches 38, 40 for detection of contact between hand-held housing 12 and the skin surface, Therapy is started upon detection proper contact).
Therefore, It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Anderson, to incorporate the teachings of Asah and provides the switching apparatus as claimed for the purpose of simultaneously activate the treatment as taught by Asah ([0067]). The modification ensures the light-emitting part is only active when correctly positioned against the skin, which prevents ineffective treatment or accidental exposure, while providing convenient and automated user experience.
Claim 41 is rejected under 35 U.S.C. 103 as being unpatentable over Anderson (US 20190240502 A1) in view of Lin (US 20080035153 A1).
Regarding claim 41, Anderson teaches the dermatologic treatment apparatus according to claim 40.
Anderson does not teach wherein the method of manufacture is repeated, so as to manufacture a plurality of dermatologic treatment apparatus and wherein each skin treatment dressing is cut from the same length of a skin treatment dressing.
In the same field of endeavor, namely a facemask roll and method for manufacturing the same, Lin teaches wherein the method of manufacture is repeated, so as to manufacture a plurality of dermatologic treatment apparatus and wherein each skin treatment dressing is cut from the same length of the skin treatment dressing. (figures 1, 6 and [0034]-[0044] manufacturing process comprising steps s01-s06, and at step s04, the steps comprises punching process to cut the each mask 62 from a facemask roll 6 having same length, the step is repeated until the pre-determined quantity of facemask is achieved).
Therefore, It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Anderson, to incorporate the teachings of Lin and provide the claimed method of manufacture for the purpose of achieving pre-determined quantity of the dermatologic treatment apparatus as taught by Lin ([0012]).
Claims 43-46, 48, 49, 51 and 52 are rejected under 35 U.S.C. 103 as being unpatentable over Anderson (US 20190240502 A1) in view of Chen (US 6096066 A).
Regarding claim 43, Anderson teaches the dermatologic treatment apparatus according to claim 1.
Anderson does not teach wherein the dermatologic treatment apparatus is flexible.
In the same field of endeavor, namely conformal patch for administering light therapy, Chen teaches wherein the dermatologic treatment apparatus is flexible (figure 1 and col 3 lines 50-65, conformal flexible patch 10).
Therefore, It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Anderson, to incorporate the teachings of Chen and provide the apparatus as claimed for the purpose of providing close fit over a non-planar portion of a patient body as taught by Chen (col 3 lines 50-65)
Regarding claim 44, Anderson teaches the dermatologic treatment apparatus according to claim 1.
Anderson does not teach wherein the dermatologic treatment apparatus is less than 2 mm thick.
In the same field of endeavor, namely conformal patch for administering light therapy, Chen teaches wherein dermatologic treatment apparatus is less than 2 mm thick (col 5 lines 1-5 preferably the maximum thickness of the flexible patch is less than 1.0 millimeters)
Therefore, It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Anderson to incorporate the teachings of Chen and provide the dermatologic treatment apparatus as claimed for the purpose of providing substantial flexibility of the device as taught by Chen (col 5 lines 1-5) which readily conform with irregularly shaped portions of the patient's body to provide a close fit.
Regarding claim 45, Anderson teaches the method according to claim 35.
Anderson does not teach wherein the dermatologic treatment apparatus is flexible.
In the same field of endeavor, namely conformal patch for administering light therapy, Chen teaches wherein the dermatologic treatment apparatus is flexible (figure 1 and col 3 lines 50-65, conformal flexible patch 10).
Therefore, It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Anderson, to incorporate the teachings of Chen and provide the apparatus as claimed for the purpose of providing close fit over a non-planar portion of a patient body as taught by Chen (col 3 lines 50-65)
Regarding claim 46, Anderson teaches the method according to claim 35.
Anderson does not teach wherein the dermatologic treatment apparatus is less than 2 mm thick.
In the same field of endeavor, namely conformal patch for administering light therapy, Chen teaches wherein dermatologic treatment apparatus is less than 2 mm thick (col 5 lines 1-5 preferably the maximum thickness of the flexible patch is less than 1.0 millimeters)
Therefore, It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Anderson to incorporate the teachings of Chen and provide the dermatologic treatment apparatus as claimed for the purpose of providing substantial flexibility of the device as taught by Chen (col 5 lines 1-5) which readily conform with irregularly shaped portions of the patient's body to provide a close fit.
Regarding claim 48, Anderson teaches the method according to claim 40.
Anderson does not teach wherein the dermatologic treatment apparatus is flexible.
In the same field of endeavor, namely conformal patch for administering light therapy, Chen teaches wherein the dermatologic treatment apparatus is flexible (figure 1 and col 3 lines 50-65, conformal flexible patch 10).
Therefore, It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Anderson, to incorporate the teachings of Chen and provide the apparatus as claimed for the purpose of providing close fit over a non-planar portion of a patient body as taught by Chen (col 3 lines 50-65)
Regarding claim 49, Anderson teaches the method according to claim 40.
Anderson does not teach wherein the dermatologic treatment apparatus is less than 2 mm thick.
In the same field of endeavor, namely conformal patch for administering light therapy, Chen teaches wherein dermatologic treatment apparatus is less than 2 mm thick (col 5 lines 1-5 preferably the maximum thickness of the flexible patch is less than 1.0 millimeters)
Therefore, It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Anderson to incorporate the teachings of Chen and provide the dermatologic treatment apparatus as claimed for the purpose of providing substantial flexibility of the device as taught by Chen (col 5 lines 1-5) which readily conform with irregularly shaped portions of the patient's body to provide a close fit.
Regarding claim 51, Anderson teaches the kit of parts according to claim 42.
Anderson does not teach wherein the dermatologic treatment apparatus is flexible.
In the same field of endeavor, namely conformal patch for administering light therapy, Chen teaches wherein the dermatologic treatment apparatus is flexible (figure 1 and col 3 lines 50-65, conformal flexible patch 10).
Therefore, It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Anderson, to incorporate the teachings of Chen and provide the apparatus as claimed for the purpose of providing close fit over a non-planar portion of a patient body as taught by Chen (col 3 lines 50-65)
Regarding claim 52, Anderson teaches the kit of parts according to claim 42.
Anderson does not expressly teach wherein the dermatologic treatment apparatus is less than 2 mm thick.
In the same field of endeavor, namely conformal patch for administering light therapy, Chen teaches wherein dermatologic treatment apparatus is less than 2 mm thick (col 5 lines 1-5 preferably the maximum thickness of the flexible patch is less than 1.0 millimeters)
Therefore, It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified Anderson to incorporate the teachings of Chen and provide the dermatologic treatment apparatus as claimed for the purpose of providing substantial flexibility of the device as taught by Chen (col 5 lines 1-5) which readily conform with irregularly shaped portions of the patient's body to provide a close fit.
Conclusion
The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Tapper (US 20190111276 A1) is cited as disclosing light therapy bandage.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to SETH HAN whose telephone number is (571)272-2545. The examiner can normally be reached M-F 0900-1700.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sarah Al-Hashimi can be reached at (571) 272-7159. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/SETH HAN/ Examiner, Art Unit 3781